Addressing Diabetes in China

26
The J&J Diabetic Vitality Program Addressing the Growing Problem of Diabetes in China tini Emily Jantz Jarrett Payne Beth Roser Drew Smith TEAM CERES INNOVATION

description

Presentation of a strategic approach to the growing problem of diabetes screening, diagnosis and care in China

Transcript of Addressing Diabetes in China

Page 1: Addressing Diabetes in China

The J&J Diabetic Vitality Program

Addressing the Growing Problem of Diabetes in China

Ray Costantini Emily Jantz Jarrett Payne Beth Roser Drew Smith

TEAM CERES INNOVATION

Page 2: Addressing Diabetes in China

A Daunting Problem

• At least 30 million diabetics in China

• 70-90% are undiagnosed

• At least 21-27 million undiagnosed Chinese diabetics - likely many more

Page 3: Addressing Diabetes in China

A Different Perspective

Increasing the diagnosis rate by only 10%

means that more than 1 million additional

Chinese diabetics will have the opportunity

to be treatedChinese character for

both “Adversity” & “Opportunity”

These Challenges Provide Opportunity

Page 4: Addressing Diabetes in China

Barriers to Diagnosis

Lack of Public Awareness

• Even among health care providers

Volume

• 5-7% prevalence

– Diagnosis of 1M requires screening

20M

– Time consuming and impractical

– Expensive

Page 5: Addressing Diabetes in China

Requires a System of Intervention

2. Screening

3. Diagnosis

4. Education

5. Retention

Vitality Centers

EZ Read Test Strips 1. Awareness

Page 6: Addressing Diabetes in China

EZ Read Diabetic Screen

• Simple reagent-based urine diagnostic test

• High levels of sugar in the blood lead to sugar in the urine

• Performed at home (FOBT model)

• Principle used in the past to monitor treatment effect

What is it?

Similar device designed to test for

urine protein

Page 7: Addressing Diabetes in China

EZ Read Diabetic Screen

• Very low cost - established technology

• Easier than a home pregnancy test

• Completely non-invasive

• Highly limited non-diabetic positives

• Bypasses lack of awareness - brings screening to the patient

Benefits

Page 8: Addressing Diabetes in China

Distribution

Bringing screening to the patient

• Provide EZ Strips in heavily trafficked pedestrian areas

• Verbal instructions and education

• Printed instruction & disease information

• Provide free J&J branded products - bandages, pens, etc.

Page 9: Addressing Diabetes in China

From Screening to Diagnosis

• Provide location of local Vitality Center in the event of positive test strip results

• Additional incentives offered at Vitality Centers» Positive EZ Test Strip results» Diagnosed with diabetes

– Glucometer test strips?– “Razor and blades” model?– Diabetic product “coupon books”?

Follow-up at Vitality Centers

Page 10: Addressing Diabetes in China

Diabetic Vitality Centers (Emily)

• This is a description of the Vitality Centers

• Additional source of undiagnosed patients via word-of-mouth

• Potential function as Co-op center

• This describes how the patients would be referred to health care providers for follow-up

Page 11: Addressing Diabetes in China

Cost Analysis

20 million People tested

x 5 Test strips per person

100 million Total test strips needed

x $0.01 Cost per test strip

$1 million Total production costs

÷ 1M Number new diagnoses

$1 Cost per new diagnosis

Test Strips

Page 12: Addressing Diabetes in China

Cost Analysis

20 million People tested

x 5 Test strips per person

100 million Total test strips needed

x $0.05 Cost per test strip

$5 million Total production costs

÷ 1M Number new diagnoses

$5 Cost per new diagnosis

Test Strips

Page 13: Addressing Diabetes in China

Cost Analysis

• Low cost

–Simplicity of structures

–Low cost staffing

• Self-sustaining through retail function

• Cost sharing through partnering

Vitality Centers

Page 14: Addressing Diabetes in China

Value Proposition

Patient and Community

• Earlier diagnosis

• Less complications and disabilities

• Better medical outcomes

• Resources

• Improved productivity among controlled diabetics

"We are responsible to the communities in which we live and work and to the world community as well." - Johnson & Johnson Credo

Page 15: Addressing Diabetes in China

Value Proposition

Health Care Providers

• Increased referrals and larger patient base

• More able to effect change

• Less time spent on patient education means more time available for treatment

"We believe our first responsibility is to the doctors, nurses and patients...” - Johnson & Johnson Credo

Page 16: Addressing Diabetes in China

Competitive Advantage

• Dramatically larger consumer base for J&J diabetic products

• Increased consumer brand recognition

• First mover advantage into undiagnosed population

• Strengthened healthcare provider and government relations

• Easily transferable to other developing markets...

"Business must make a sound profit. We must experiment with new ideas. Research must be carried on, innovative programs developed… New equipment must be purchased, new facilities provided, and new products launched." - Johnson & Johnson Credo

Page 17: Addressing Diabetes in China

Competitive Advantage (Continued)

Easily transferable to other developing markets...

India?

Estimated 22 million undiagnosed diabetics...

Page 18: Addressing Diabetes in China

Implementation

• Number of newly diagnosed diabetics as a percentage of EZ Read kits provided

• Relative utilization of various Vitality Center locations

• Rate of diabetic complications among newly diagnosed diabetics

• Number of successful physician referrals

• Number of diabetic supplies sold

• Change in Market Share, Sales & Profits

Metrics of Success

Page 19: Addressing Diabetes in China

Implementation Plan

Initial Steps

Partnering, Technology Acquisition, Design and Production

2008 2009 2010 2011 2012 2013

Vitality CenterPartnering

EZ Test Strip Design & Production

Page 20: Addressing Diabetes in China

Implementation Plan

2008 2009 2010 2011 2012 2013

BeijingVitality CenterSite Selections EZ Test Strip

Distribution Site Selection

First 6 Months

Test Strip distribution sites chosen based on Vitality Center locations

Page 21: Addressing Diabetes in China

Implementation Plan

Second 6 Months

Begin staffing and training 1-2 months prior to initial EZ Test Strip distribution

2008 2009 2010 2011 2012 2013

Initial Vitality Center

Completion

EZ Test Strip Distribution

Staffing & Training

Page 22: Addressing Diabetes in China

Implementation Plan

Year 2

Notes on this phase go here

2008 2009 2010 2011 2012 2013

Evaluation, Feedback and

Adjustment

First 6 Monthsof Operations

Page 23: Addressing Diabetes in China

Continued Feedback, Expansion and Refinement throughout China

Implementation Plan

2008 2009 2010 2011 2012 2013

Second Phaseof Beijing

Vitality Centers

Expand to Second Major Chinese

Metropolitan Area

Years 3 through 5

Evaluation of India Sites?

Page 24: Addressing Diabetes in China

Implementation Plan

• Partner with major insulin production company

• Design and production of EZ Test Strips

• Site Selection of initial Beijing Vitality Centers

• Initial EZ Test Strip distribution site selection

• Vitality Center staffing and training

• Design and completion of initial Vitality Centers

• Initial distribution of EZ test strips

• Evaluation of Success Matrices with feedback and adjustment

• Second phase Vitality Centers and EZ Test Strip distribution

• Evaluation for India Vitality Center and EZ Test Strip Distribution sites

Schedule (I’ve left this in as a reference only)

Page 25: Addressing Diabetes in China

Conclusion

Page 26: Addressing Diabetes in China

Question and Answer